L-Glutamicacid,N-[4-[[3-(2,6-diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)propyl](12,12-dihydroxy-12-oxido-1,5-dioxo-11-oxa-3-thia-6-aza-12-phosphadodec-1-yl)amino]benzoyl]-(9CI) (153488-09-6)

Identification
Name:	L-Glutamicacid,N-[4-[[3-(2,6-diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)propyl](12,12-dihydroxy-12-oxido-1,5-dioxo-11-oxa-3-thia-6-aza-12-phosphadodec-1-yl)amino]benzoyl]-(9CI)
Synonyms:	L-Glutamicacid,N-[4-[[3-(2,6-diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)propyl][[[2-oxo-2-[[4-(phosphonooxy)butyl]amino]ethyl]thio]acetyl]amino]benzoyl]-;BW 1476U89
CAS:	153488-09-6
Molecular Formula:	C27H38 N7 O12 P S
Molecular Structure:
Properties
Safety Data

Other Product

L-Proline,1-[10-(3-aminopropyl)-12-cyclobutyl-5-hydroxy-3-methyl-5-oxido-1,8,12-trioxo-6-(phenylmethyl)-4-oxa-7,11-diaza-5-phosphadodec-1-yl]-
L-Alanine,N-[3-(4-azido-3-iodophenyl)-1-oxopropyl]-3-[[9,13-dihydroxy-10,10-dimethyl-13-oxido-4,8-dioxo-13-[(3'-O-phosphono-5'-adenylyl)oxy]-12-oxa-3,7-diaza-13-phosphatridec-1-yl]dithio]-,(R)- (9CI)
Hexadecanoic acid,1-[3-hydroxy-3-oxido-9-oxo-12-[(5-sulfo-1-naphthalenyl)amino]-2,4-dioxa-7,10-diaza-3-phosphadodec-1-yl]-1,2-ethanediyl ester
Spiro[furan-3(2H),7'(4'H)-naphtho[2,1-g]quinoline]-4',5,6',10'(4H,6'aH,7'aH)-tetrone,1',4'a,5',8',9',11',12'a,12'b-octahydro-2',5',7'a,12'a-tetramethyl-11'-[[(2R,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]methyl]-,(3S,4'aS,5'S,6'aR,7'aR,12'aS,12'bS)-rel-(+)- (9CI)
2-Oxa-4,6,11-triazadodec-4-en-12-oicacid, 10-carboxy-3-oxo-1-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-,12-(phenylmethyl) ester, (10R)- (9CI)
L-Valinamide,N-[9-hydroxy-9-oxido-1,4,15-trioxo-12-[(1-oxohexadecyl)oxy]-8,10,14-trioxa-5-aza-9-phosphatriacont-1-yl]-D-phenylalanyl-3-(1-naphthalenyl)-D-alanyl-(2S)-2-piperidinecarbonyl-(2S)-2-hydroxy-4-methylpentanoyl-(9CI)
12-Oxa-2,3,7,10-tetraazatridecanoicacid,5-hydroxy-3-[(4-methoxyphenyl)methyl]-9-(1-methylethyl)-8,11-dioxo-6-(phenylmethyl)-13-(2-pyridinyl)-,3-pyridinylmethyl ester, [5S-(5R*,6R*,9R*)]- (9CI)
1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H
Sauvagin,1-de(5-oxo-L-proline)-2-deglycine-3-de-L-proline-4-de-L-proline-5-de-L-isoleucine-6-de-L-serine-7-de-L-isoleucine-8-de-L-asparticacid-9-de-L-leucine-10-de-L-serine-11-de-L-leucine-12-de-L-glutamicacid-13-de-L-leucine-14-de-L-leucine-15-de-L-arginine-16-de-L-lysine- (9CI)
Xanthylium,9-[2-carboxy-5-[[(9R)-6- hydroxy-6-oxido-12-oxo-9-[(1-oxohexadecyl)- oxy]-1-thioxo-5,7,11-trioxa-2-aza-6- phosphaheptacos-1-yl]amino]phenyl]-3,6-bis- (dimethylamino)-,inner salt,compd. with N,N-diethylethanamine (1:1)
1/C8H10N4OS/c1-5-4-6(13)12-8(11(5)2)9-7(10-12)14-3/h4H,1-3H
2-Oxa-4,6,11-triazadodecan-12-oicacid, 10-carboxy-5-imino-3-oxo-1-phenyl-6-[(phenylmethoxy)carbonyl]-,12-(phenylmethyl) ester, monosodium salt, (S)- (9CI)
13-Oxa-2,6,11-triazapentadecanoic acid,6-[3-[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutyl]amino]propyl]-14,14-dimethyl-12-oxo-, 1,1-dimethylethyl ester
11-Deoxy-3-des(hexopyranosyloxy)-6-O-methyl-3-oxo-N-[4-[4-(3-pyridyl)imidazol-1-yl]butyl]amino erythromycin A 11-N,12-O-cyclic carbamate
(2S)-1-{[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino}-4-methyl-1-oxopentan-2-yl 1-{N-[12-(hexadecanoyloxy)-9-hydroxy-9-oxido-4,15-dioxo-8,10,14-trioxa-5-aza-9lambda~5~-phosphatriacontan-1-oyl]-D-phenylalanyl-3-(naphthalen-1-yl)-D-alanyl}piperidine-4-carbo
1/C12H16/c1-9-6-7-12-10(2)4-3-5-11(12)8-9/h3-5,9H,6-8H2,1-2H
(5S,4’S,6’S,8’E,10’E,12’E)-1-benzoyl-5-benzyl-3-phenylseleno-3-[4’,6’,12’-trimethyl-4’-(2-trimethylsilylethoxymethoxy)-1’-oxotetradeca-8’,10’,12’-trienyl]pyrrolidin-2-one
Carbamic acid, [2-(ethenylthio)ethyl]-,7-oxo-3-oxa-11-thia-6,8-diazatridec-12-en-1-yl ester
1/C7H10N4O/c1-2-9-10-7(8-1)11-3-5-12-6-4-11/h1-2H,3-6H
L-Glutamicacid,N-[4-[[(2,4-diamino-1,5-dihydro-5-oxopyrido[2,3-d]pyrimidin-6-yl)methyl]amino]benzoyl]-(9CI)